Search
Descriptor English: Medazepam
Descriptor Spanish: Medazepam
Descriptor medacepam
Entry term(s) medazepam
Scope note: Derivado de las benzodiazepinas, que se utiliza en el tratamiento de la ansiedad. Tiene propiedades sedantes, relajante muscular y anticonvulsivante. Uno de sus metabolitos es el DIAZEPAM y uno de sus productos de excreción es el OXAZEPAM.
Descriptor Portuguese: Medazepam
Descriptor French: Médazépam
Entry term(s): Chlorhydrate de médazépam
Ro 5-4556
Ro54556
Tree number(s): D03.633.100.079.080.550
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008472
Scope note: A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Anticonvulsants
Hypnotics and Sedatives
Muscle Relaxants, Central
Anti-Anxiety Agents
GABA Modulators
Registry Number: P0J3387W3S
CAS Type 1 Name: 1H-1,4-Benzodiazepine, 7-chloro-2,3-dihydro-1-methyl-5-phenyl-
DeCS ID: 8641
Unique ID: D008472
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1974/11/14
Revision Date: 2017/05/24
Médazépam - Preferred
Concept UI M0013187
Preferred term Médazépam
Ro 5-4556 - Narrower
Concept UI M0013188
Preferred term Ro 5-4556
Entry term(s) Ro54556
Chlorhydrate de médazépam - Narrower
Concept UI M0330117
Preferred term Chlorhydrate de médazépam



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey